(Q48375577)

11 February 2018

title

Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients (English)

1 reference

11 February 2018

0 references

0 references

1 reference

Lars-Olov Wahlund

1

1 reference

11 February 2018

Kaj Blennow

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 March 2003

1 reference

11 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

11 February 2018

volume

339

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

99-102

1 reference

11 February 2018

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Longitudinal stability of CSF tau levels in Alzheimer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901483-0

7 January 2021

10.1016/S0304-3940(02)01483-0

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018